These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12270466)
21. Viral infections in renal transplant recipients: an evolutionary problem. Charpentier B Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452 [No Abstract] [Full Text] [Related]
22. [Treatment and prevention of chronic viral hepatitis]. Lumio J; Vuoristo M Duodecim; 1994; 110(20):1883-92. PubMed ID: 7555802 [No Abstract] [Full Text] [Related]
23. Cytomegalovirus infection after liver transplantation using different prophylaxes. Kornberg A; Grube T; Hommann M; Schotte U; Scheele J Transplant Proc; 2001; 33(7-8):3624-5. PubMed ID: 11750539 [No Abstract] [Full Text] [Related]
24. Hepatitis update: the role of primary care practitioners in prevention, treatment, and vaccination. Margolis HS Ethn Dis; 2002; 12(1):S2-33-5. PubMed ID: 11913636 [No Abstract] [Full Text] [Related]
25. [Acute viral hepatitis A, B, C, D and E: epidemiology, etiology, diagnosis, course, prevention]. Zarski JP; Leroy V; Maynard-Muet M Rev Prat; 1998 Sep; 48(14):1609-14. PubMed ID: 9814059 [No Abstract] [Full Text] [Related]
26. Reducing the risk of viral infection in renal transplantation. Tibbles LA Transplant Proc; 2008 Dec; 40(10 Suppl):S48-51. PubMed ID: 19100908 [TBL] [Abstract][Full Text] [Related]
27. [Viral hepatitis--trends]. Manciuc C; Dorobăţ C; Filip-Ciubotaru FM Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):327-31. PubMed ID: 20700962 [TBL] [Abstract][Full Text] [Related]
29. Changes in serological markers of hepatitis B virus after renal transplantation. Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006 [TBL] [Abstract][Full Text] [Related]
30. Minimizing the toxicity of antilymphocyte antibody therapy. Pascual M; Rubin RH; Cosimi AB Transplant Proc; 1996 Aug; 28(4):2113-4. PubMed ID: 8769171 [No Abstract] [Full Text] [Related]
31. Management of hepatitis B in special patient populations. Wang HS; Han SH Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028 [TBL] [Abstract][Full Text] [Related]
32. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
33. [Transfusion safety]. Aprili G Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537 [No Abstract] [Full Text] [Related]
35. New challenges in viral hepatitis. Thomas D; Zoulim F Gut; 2012 May; 61 Suppl 1():i1-5. PubMed ID: 22504915 [TBL] [Abstract][Full Text] [Related]
36. [Epidemiological aspects of viral hepatitis: immunogenicity of hepatitis B vaccine administered to children and adolescents]. del Rey Calero J An R Acad Nac Med (Madr); 1992; 109(2):261-96; discussion 296-8. PubMed ID: 1463144 [No Abstract] [Full Text] [Related]
37. Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients. Chak WL; Choi KS; Wong KM; Chan YH; Chau KF; Li CS Transplant Proc; 2003 Feb; 35(1):280-1. PubMed ID: 12591399 [No Abstract] [Full Text] [Related]
38. Effective strategies to prevent cytomegalovirus disease after renal transplantation. Chapman JR Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809 [No Abstract] [Full Text] [Related]